文献速递重症综合管理与镇静镇痛心脑血管急症

神经重症患者经外周置入中心静脉导管时手臂序贯气压压缩治疗:一项随机试验

Sequential Pneumatic Compression in the Arm in Neurocritical Patients with a Peripherally Inserted Central Venous Catheter: A Randomized Trial.
PubMed 文献 · Neurocrit Care · 2020-01-01
一句话结论神经重症患者PICC置管后手臂序贯气压压缩治疗增加上肢深静脉血栓风险,该试验因治疗组血栓过多而提前终止,结果不支持该用法。

该研究为单中心随机对照试验的回顾性分析,纳入2014年1月至2016年10月ICU内留置PICC且未接受抗凝治疗的危重神经疾病患者,1:1随机分为手臂佩戴定制序贯气压压缩装置(SCD)组与对照组,主要终点为超声检测的上肢深静脉血栓(UE DVT)。随机77例后因治疗组DVT过多而终止,UE DVT共18例(29.0%),SCD组13/31(41.9%)vs 对照组5/31(16.1%),p=0.049;校正交叉后差异仍有统计学意义(12/28 [43.0%] vs 6/34 [17.6%],p=0.048)。有症状UE DVT(n=3)及无下肢DVT证据的肺栓塞(n=2)仅见于未佩戴手臂SCD的患者。结论认为结果不支持手臂SCD用于DVT预防,但该策略仍可能值得进一步研究。

要点

  • 神经重症ICU患者PICC置管后手臂SCD组UE DVT发生率41.9%(13/31),显著高于对照组16.1%(5/31),p=0.049。
  • 校正交叉后SCD组UE DVT仍高于对照组(12/28 [43.0%] vs 6/34 [17.6%],p=0.048)。
  • 试验因治疗组DVT过多而提前终止,随机77例后停止。
  • 有症状UE DVT(n=3)和无下肢DVT证据的肺栓塞(n=2)仅见于未佩戴手臂SCD的患者。
  • 作者结论:结果不支持手臂SCD用于DVT预防,但该策略仍可能值得进一步研究。

适用人群与场景

  • ICU住院的危重神经疾病患者,已留置PICC且未接受抗凝治疗。
  • 研究时间范围为2014年1月至2016年10月。

研究设计与关键结果

  • 研究类型:单中心随机对照临床试验的回顾性分析;样本量77例,随机1:1分为手臂定制SCD组与对照组;主要终点为超声检测的UE DVT。
  • UE DVT共18例(29.0%),SCD组13/31(41.9%)vs 对照组5/31(16.1%),p=0.049。
  • 校正交叉后SCD组12/28(43.0%)vs 对照组6/34(17.6%),p=0.048。
  • 有症状UE DVT(n=3)及无下肢DVT证据的肺栓塞(n=2)仅见于未佩戴手臂SCD的患者。
  • 试验因治疗组DVT过多而提前终止。

证据类型、等级与局限

  • 证据类型:单中心随机对照临床试验的回顾性分析;试验注册号NCT01670188。
  • 作者结论:结果不支持手臂SCD用于DVT预防,但该策略仍可能值得进一步研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该试验结果不支持在神经重症ICU的PICC置管患者中使用手臂SCD预防UE DVT;作者认为该策略仍可能值得进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Peripherally inserted central venous catheters (PICCs) are increasingly used for parenteral access in critically ill hospitalized patients, but they increase the incidence of upper extremity deep venous thrombosis (UE DVT). Sequential compression devices (SCDs) applied to the legs effectively reduce lower extremity DVT, but have not been tested in the arms. Our objective was to determine whether SCDs applied to the arm may reduce the risk of PICC-associated UE DVT.

METHODS: This was a retrospective study of randomized, single-center, controlled clinical trial on patients hospitalized in the intensive care unit with critical neurological illness who had a PICC and were not receiving anticoagulants. Between January 2014 and October 2016, patients were randomized 1:1 to an intervention group having a custom SCD applied to the arm harboring the PICC or to a control group. The primary endpoint was ultrasound-detected UE DVT.

RESULTS: Following randomization of 77 subjects, the study was terminated due to excess DVT in the treatment arm. UE DVT was detected in 18 subjects (29.0%), and it was more frequent among those in the SCD group (13/31 [41.9%] vs. the control group 5/31 [16.1%]; p = 0.049). After accounting for crossovers, the difference was still significant (12/28 [43.0%] vs. 6/34 [17.6%]; p = 0.048). Yet, symptomatic UE DVT (n = 3) and pulmonary embolism without evidence of lower extremity DVT (n = 2) were only observed in patients who were not wearing the SCD on the arm.

CONCLUSIONS: Although UE DVT is commonly associated with PICC use, the results of this trial do not support the use of SCD on the arm for DVT prevention. Further research on this strategy may nonetheless be justified.

TRIAL REGISTRATION: This trial was registered in ClinicalTrials.gov under the identifier NCT01670188.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Rabinstein AA, Hellickson JD, Macedo TA, et al. Sequential Pneumatic Compression in the Arm in Neurocritical Patients with a Peripherally Inserted Central Venous Catheter: A Randomized Trial. Neurocrit Care. 2020. PMID: 31236782. doi:10.1007/s12028-019-00765-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。